In the second half of the year, these policies have had a huge impact on the pharmaceutical industry!

"
Pharmaceutical Network Policy and" unknowingly, 2020 has been quietly more than halfFrom the beginning of the development of the pharmaceutical industry, the first half of this year the pharmaceutical market can be described as volatile, industry policy release intensive, let people catch upSo, in the coming second half of the year, the pharmaceutical industry will be affected by what pharmaceutical policies? Below, with the author to take stock!the 3rd batch of volume procurement is coming
June 18 afternoon, the national collection meeting held online, the industry accordingly believes that the third batch of national belt procurement is about to startAccording to recent information, a new round of national rules, reports, etchave also flowed outAmong them, the main contents include: all full competition conditions of the product, will be included in a new round ofof raw materials procurement, regardless of theraw materialsimpurities, will implement the balance incentive mechanism, hospital reporting will be the key, local reporting volume and balance retention policy training will be launched this week, July 3 to complete the reportin general, the basic rules of the third batch of volume procurement remain unchanged, the selection of product range for fully competitive varieties, that is, the original research drug and over-evaluated varieties at least "1 plus 2" patternIn this context, the future generic prices will not be significantly higher than the average cost, may become the norm However, due to the different size of enterprises, the average cost of differences, how to achieve the scale effect will become one of the long-term research topics of generic pharmaceutical enterprises the Measures for the Administration of Drug Registration and the Measures for the Supervision and Administration of Drug Production march 30, 2020, the State Administration of Market Supervision and Administration announced the new version of the Measures for the Administration of Drug Registration and the Measures for the Supervision and Administration of Drug Production, which will come into effect on July 1, 2020 industry expects that the second half of the relevant chemical drugs, Chinese medicine and biological products related to the registration of supporting documents will be gradually issued, or will affect the domestic drug registration declaration pattern, especially the recognition of imported drugs of overseas clinical data supporting policies will have a further impact on the domestic competition for new drugs In addition, due to the emphasis on associated review, API, accessories, pharmaceutical packagematerials, such as the status or significantly improved .　　The implementation of the DRG pilot June 5, 2019, the State Health Insurance Administration issued the "Notice of the List of National Pilot Cities paying by disease diagnosis-related subgroups", identifying 30 cities as pilot cities for DRG paying countries According to the national "top-level design, simulation test, actual payment" three-year three-step thinking, 2020 simulation operation for DRG implementation, will be a crucial step in the three-step The second half of the year is a critical period for DRG simulation operation evaluation to further improve, and to review the simulation operation and deploy the next step medical insurance electronic vouchers will be promoted throughout the country
Early this year, the Office of the State Medical Security Administration issued a "Notice on the promotion and application of medical insurance electronic vouchers", decided to promote the application of medical insurance electronic vouchers nationwide By the end of August, all localities should realize the application of medical insurance e-voucher seeking medicine, public service inquiry and personal insurance information query online By the end of December, more than 30% of local insured persons in various places will be activated with health insurance electronic vouchers, and the use of health insurance e-vouchers will be supported by major pharmacies and at least one hospital in each prefecture-level city , medical insurance electronic vouchers for the national medical insurance online business identity credentials, with its continuous promotion throughout the country, the future realization of medical insurance off-site interoperability, in the field can also easily seek medical treatment will become the general trend continue to correct irregularities in the pharmaceutical industry
June 5, the State Health and Health Commission, the Ministry of Industry and Information Technology, the Ministry of Finance, the Ministry of Commerce, the State Administration of Taxation, the State Administration of Market Supervision and Administration, the State Administration of Medical Insurance, the State Administration of Traditional Chinese Medicine and other nine ministries jointly issued the "2020 to correct the pharmaceutical purchase and sale of the field and medical services in the field of improper work points notice", in several important areas for the work of medical work Predictably, the medical anti-corruption work in the second half of 2020 will continue to attract the attention of the industry, and have a huge impact on the industry medical insurance catalogue is about to be dynamically adjusted
on April 29, the State Administration of Health Insurance issued the Interim Measures for the Administration of Drug Use in Basic Medical Insurance (Draft for Comments), which includes the determination and adjustment of the scope of basic medical insurance drug use, as well as the payment, management and supervision of basic medical insurance medication According to the previous health insurance dynamic adjustment once a year, the second half or will start again, and drug prices will again become the focus of attention in the industry concluding 2020, which coincides with the collective effect of reforms in the pharmaceutical industry Under the pressure of various policies, the survival of the industry will intensify, the strong and strong, do not understand the flexibility will not be random enterprises will be accelerated elimination.